isosorbide-5-mononitrate has been researched along with Arteriosclerosis, Coronary in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 6 (54.55) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Al-Lamee, R; Davies, JR; Foley, M; Francis, DP; Ganesananthan, S; Gerber, R; Howard, J; Keeble, TR; Malik, IS; Nijjer, S; Nowbar, AN; O'Kane, P; Petraco, R; Rajkumar, CA; Seligman, H; Sen, S; Sharp, ASP; Shun-Shin, M; Tang, KH | 1 |
Lai, J; Shang, Y; Sun, J; Wu, B; Zhu, J | 1 |
Ağaç, MT; Aslan, AO; Çavuşoğlu, İG; Çelik, Ş; Dursun, İ; Erkan, H; Kırcı, DC; Kırış, G; Korkmaz, L; Yılmaz, AS | 1 |
Akgun, A; Günel, SE | 1 |
Lau, CP; Pong, V; Siu, CW; Tse, HF; Yiu, KH | 1 |
Godard, S; Haïat, R; Hanania, G; Maalouf, B; Martelet, M; Michel, D; Olive, T | 1 |
Bellamy, GR; Csanady, M; Edes, I; Gillies, H; Jackson, G; Keltai, M; Lisa, L; Widimsky, P | 1 |
Knapik, P; Nadziakiewicz, P; Nowak, D; Ziora, D | 1 |
Brum, EM; Fanti, L; Manfroi, WC; Oliveira, J; Perin, A; Raudales, JC; Ribeiro, JP; Zago, AJ | 1 |
Alekseeva, IA; Chotchaev, KhKh; Lupanov, VP; Naumov, VG; Vasil'eva, NN | 1 |
Aviram, EE; Elhayani, A; Galai, N; Lifshitz, M; Paran, E; Peled, R; Reuveni, H; Sherf, M | 1 |
8 trial(s) available for isosorbide-5-mononitrate and Arteriosclerosis, Coronary
Article | Year |
---|---|
Achieving Optimal Medical Therapy: Insights From the ORBITA Trial.
Topics: Amlodipine; Bisoprolol; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Fractional Flow Reserve, Myocardial; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isosorbide Dinitrate; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Ranolazine; Treatment Outcome; Vasodilator Agents | 2021 |
Long-term isosorbide mononitrate treatment impairs endothelial function in patients with coronary artery disease.
Topics: Administration, Oral; Aged; Biomarkers; Brachial Artery; C-Reactive Protein; China; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Endothelium, Vascular; Female; Humans; Isosorbide Dinitrate; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prospective Studies; Superoxide Dismutase; Time Factors; Treatment Outcome; Vasodilation; Vasodilator Agents | 2013 |
Comparison of exercise-rest-reinjection Tl-201 imaging and rest sublingual isosorbide dinitrate Tc-99m MIBI imaging for the assessment of myocardial viability.
Topics: Administration, Sublingual; Chronic Disease; Coronary Artery Disease; Exercise; Female; Heart; Hemodynamics; Humans; Injections; Isosorbide Dinitrate; Male; Middle Aged; Myocardium; Rest; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2009 |
[Coronary artery disease observed in general hospitals: ETTIC study. Comparison between trimetazidine and mononitrate isosorbide for patients receiving betablockers].
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Coronary Artery Disease; Drug Therapy, Combination; Exercise Test; Hospitals, General; Humans; Isosorbide Dinitrate; Middle Aged; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2002 |
Hemodynamic effects of sildenafil citrate and isosorbide mononitrate in men with coronary artery disease and erectile dysfunction.
Topics: Adult; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2005 |
Moderate exercise decreases nitric oxide exhalation in patients with stable coronary artery disease.
Topics: Breath Tests; Coronary Artery Disease; Exercise; Exhalation; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors | 2006 |
[Acute effects of isosorbide mononitrate on blood circulation and myocardial ischemia in patients with coronary atherosclerosis].
Topics: Adult; Aged; Aged, 80 and over; Cardiac Catheterization; Cineangiography; Coronary Artery Disease; Female; Hemodynamics; Humans; Injections, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Vasodilator Agents; Ventricular Function, Left | 1995 |
[Comparative study of isosorbide dinitrates and mononitrates in patients with ischemic heart disease and stable angina pectoris caused by stenosing coronary atherosclerosis].
Topics: Aged; Angina Pectoris; Coronary Artery Disease; Coronary Disease; Cost-Benefit Analysis; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Vasodilator Agents | 2000 |
3 other study(ies) available for isosorbide-5-mononitrate and Arteriosclerosis, Coronary
Article | Year |
---|---|
Relationship between Nitrate-Induced Headache and Coronary Artery Lesion Complexity.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Female; Headache; Humans; Isosorbide Dinitrate; Male; Middle Aged; Risk Assessment; Risk Factors; Severity of Illness Index; Vasodilator Agents | 2015 |
Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention.
Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; Hong Kong; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Vasodilator Agents | 2011 |
The prescription pattern of oral nitrates in coronary artery disease. Appropriateness and cost considerations.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Costs and Cost Analysis; Delayed-Action Preparations; Drug Prescriptions; Drug Utilization; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitrates; Practice Patterns, Physicians'; Vasodilator Agents | 2001 |